THCA

THCA & Disease Biology

What studies of inflammation, signaling pathways, and disease models reveal about THCA, and where the evidence still falls short.

THCA and Cancer, Part 2

Where Modulation May Matter

THCA does not need to act directly on a tumor to influence biology that matters in cancer. A compound can shift the conditions surrounding a tumor cell, change how immune cells behave when they encounter it, alter inflammatory signaling in…

Read More

THCA and Cancer, Part 1

The Biology THCA Would Have to Influence

Where Modulation May Matter Most people carry a fairly simple picture of cancer: cells that have slipped free of the usual restraints on growth, dividing when they should stop and eventually forming a mass that does not belong there. That…

Read More

THCA and Multiple Sclerosis

What the Evidence Shows So Far

Multiple sclerosis is not defined by inflammation alone. Its biology depends on a particular interaction between peripheral immune activity and the central nervous system, with glial cells, myelin, and nerve tissue all becoming part of the disease process. Any relevance…

Read More

THCA and Psoriasis

How the Biology May Intersect

How the Biology May Intersect Most questions about a compound and a disease start in the wrong place. They start with efficacy: does it work, does it help, does it change the course of the condition. Those are legitimate questions,…

Read More